Peptide Stack Research Guide
A structured reference for researchers investigating multi-peptide protocols. Covers synergistic mechanisms, common research pairings, and goal-based stack design.
What Is a Research Stack?
A peptide stack is a combination of two or more synthetic peptides investigated together in a research protocol. Stacking is applied when individual peptides act on distinct but complementary biological pathways, potentially producing additive or synergistic outcomes in cell or tissue models that neither compound achieves alone.
Stackpure offers 12 pre-formulated stack products and a Stack Builder tool that lets researchers filter all 204 SKUs by research goal and assemble custom combinations.
Common Research Combinations
BPC-157 targets NO pathway and cytoprotection. TB-500 drives actin polymerisation and cell migration. Complementary pathways in tissue repair models.
CJC-1295 acts on GHRH receptors; Ipamorelin on ghrelin receptors. Dual-pathway GH stimulation studied in pituitary cell models.
GHK-Cu promotes collagen synthesis and wound healing signals. TB-500 supports cell migration. Combined in dermal repair cell culture models.
Epithalon studied for telomerase activation; DSIP for delta sleep induction in neuronal models. Combined in circadian rhythm and longevity research.
Semax is an ACTH analogue studied for BDNF upregulation. Selank is a tuftsin analogue studied for GABA-A modulation. Complementary neuroprotective pathways.
Stacks by Research Goal
Stack Builder
Use the Stackpure Stack Builder to filter by research goal and assemble a custom combination from the 204-SKU catalog. The tool highlights peptides studied in relevant in vitro literature for each goal category.
Open Stack Builder →Frequently Asked Questions
What is a peptide stack in research?
A peptide stack refers to the simultaneous or sequential use of two or more research peptides in an in vitro or pre-clinical protocol. Stacks are investigated when individual peptides act on complementary biological pathways, potentially producing additive or synergistic effects in cell or tissue models.
Why are BPC-157 and TB-500 often studied together?
BPC-157 is studied for its effects on nitric oxide pathway modulation and cytoprotection at the cellular level, while TB-500 (Thymosin Beta-4) is researched for its role in actin polymerisation and cell migration. In vitro models suggest the two act on distinct but complementary repair-related pathways, making them a commonly paired combination in recovery research.
How is a CJC-1295 and Ipamorelin stack researched?
CJC-1295 is a GHRH analogue studied for growth hormone-releasing properties, while Ipamorelin is a selective ghrelin receptor agonist. Research protocols investigate combining them because they act through different receptor pathways, GHRH receptor vs. ghrelin receptor, to stimulate GH release, potentially producing a broader or more sustained effect in pituitary cell models.
What stack options does Stackpure offer?
Stackpure offers pre-formulated research stacks including BPC-157 + TB-500 (vial and pre-mixed), GHK-Cu + TB-500, BPC-157 + GHK-Cu + Thymosin Alpha-1, Epithalon + DSIP, Thymalin + Epithalon, and Kisspeptin + PT-141. Individual peptides across all 204 SKUs can also be combined via the Stack Builder tool.
How do I design a research protocol using the Stack Builder?
The Stackpure Stack Builder filters the 204-SKU catalog by research goal (e.g. recovery, cognitive, anti-aging) and suggests peptides used in relevant published in vitro studies. Select a goal, review the suggested peptides and their mechanisms, then add individual or pre-mixed stack products to your cart.